Market Overview

Piper Jaffray Reiterates Overweight Rating, $100 PT on athenahealth

Related ATHN
Summit Medical Group and Summit Strategic Solutions Partner With athenahealth to Advance Population Health
Top 4 Mid-Cap Stocks In The Healthcare Information Services Industry With The Highest ROA

In a report published Monday, Piper Jaffray & Co. reiterated its Overweight rating and $100.00 price target on athenahealth (NASDAQ: ATHN).

Piper Jaffray noted, “Earlier today, ATHN announced signing a definitive agreement to acquire EPOC for $11.75 per share. The deal is expected to be financed through the cash in hand and the available credit facility per the company. We believe this deal will bring more awareness to ATHN's services and is likely to fuel ATHN's growth in adding new physicians. The deal also diversifies the company's revenue mix into Pharma services. The acquisition is expected to be accretive to 2013 estimates per the company. We believe this will help in accelerating physician adds at a reasonable cost and also provide new opportunities in monetizing their physician network. Maintain OW, $100 price target.”

athenahealth closed on Friday at $76.35.

Latest Ratings for ATHN

Jul 2015Canaccord GenuityInitiates Coverage onHold
Jun 2015OppenheimerInitiates Coverage onOutperform
Mar 2015RW BairdInitiates Coverage onOutperform

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Piper Jaffray & Co.Analyst Color Reiteration Analyst Ratings


Related Articles (ATHN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters